Drug intelligence / Profile preview

Synacthen Depot

Development stage
Unknown
Lead developer
Mallinckrodt
Modality
Peptides
Administration
Intramuscular
01

Overview

Synacthen Depot is a synthetic formulation of tetracosactide (also known as tetracosactrin), which consists of the first 24 amino acids of the naturally occurring human adrenocorticotropic hormone (ACTH). This synthetic polypeptide exhibits the full biological activity of natural ACTH but is less immunogenic. In the Depot formulation, tetracosactide is adsorbed onto a zinc phosphate complex, which allows for sustained release and a prolonged duration of action (up to 24-48 hours) following intramuscular injection. It acts as an agonist at the **melanocortin 2 receptor (MC2R)** in the adrenal cortex, stimulating the synthesis and secretion of glucocorticoids (primarily cortisol), mineralocorticoids, and androgens. Clinically, it is used for the diagnosis of adrenocortical insufficiency via the ACTH stimulation test and as a therapeutic agent for conditions such as infantile spasms (West Syndrome), acute exacerbations of multiple sclerosis, and various rheumatic or nephrotic disorders where long-term corticosteroid stimulation is indicated.

Brand names
Synacthen DepotSynachten DepotTetracosactide DepotSynacthen Retard
Other names
tetracosactide zinc phosphatetetracosactrin zinc phosphatesynthetic ACTH 1-24 depottetracosactide zinc hydroxide complex
02

Targets

MC2R (Adrenocorticotropic Hormone Receptor)

Beyond the preview

Go deeper on Synacthen Depot.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synacthen Depot.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call